Scarica l'app Stockscreener
37.24
3.60%
-1.39
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Soleno Therapeutics Inc Borsa (SLNO) Ultime notizie
Soleno Therapeutics stock hits 52-week low at 37.95 USD By Investing.com - Investing.com Australia
Soleno Therapeutics (NASDAQ:SLNO) Sets New 1-Year LowTime to Sell? - MarketBeat
Is Soleno Therapeutics Inc. currently under institutional pressure2025 Key Lessons & Intraday High Probability Alerts - mfd.ru
SLNO: Strong market uptake, stable safety, and robust reimbursement support ongoing growth - TradingView
Why is Soleno Therapeutics Inc. stock going downGap Up & Safe Entry Trade Reports - mfd.ru
Soleno Therapeutics stock hits 52-week low at 37.95 USD - Investing.com
Why Soleno Therapeutics Inc. (6XC) stock is listed among top recommendationsJuly 2025 Reactions & Weekly Watchlist for Hot Stocks - mfd.ru
Soleno Therapeutics to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026, at 4:30 PM ET - The Manila Times
Rare disease biotech Soleno sets Feb. 25 call on 2025 results - Stock Titan
Soleno Therapeutics prices $200M public offering - MSN
Soleno Therapeutics (SLNO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Eastern Progress
Pullback Watch: Why is Soleno Therapeutics Inc. stock going downMarket Growth Report & Fast Moving Market Watchlists - baoquankhu1.vn
Why a biotech is drawing attention to a rare disease at the Super Bowl - Medical Marketing and Media
Soleno Therapeutics (NASDAQ:SLNO) Lowered to "Hold" Rating by Zacks Research - MarketBeat
(SLNO) Movement as an Input in Quant Signal Sets - Stock Traders Daily
What Soleno Therapeutics (SLNO)'s VYKAT XR Momentum and 2025 Outlook Could Mean For Shareholders - Sahm
VYKAT XR Launch Momentum Could Be A Game Changer For Soleno Therapeutics (SLNO) - Yahoo Finance
A Look At Soleno Therapeutics (SLNO) Valuation As VYKAT XR Launch Shapes A “Transformational” 2025 - Yahoo Finance
A Look At Soleno Therapeutics (SLNO) Valuation After VYKAT XR Launch And Upcoming 2025 Business Updates - Sahm
Published on: 2026-02-03 13:03:09 - baoquankhu1.vn
Down 18.3% in 4 weeks, here's why Soleno Therapeutics (SLNO) looks ripe for a turnaround - MSN
Soleno Therapeutics (NASDAQ:SLNO) Stock Price Up 8.3%Time to Buy? - MarketBeat
Soleno Therapeutics stock jumps nearly 9% today — what SLNO traders are watching next - TechStock²
Down 18.3% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround - Yahoo Finance
Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Compelling 190% Upside Potential - DirectorsTalk Interviews
Universal Beteiligungs und Servicegesellschaft mbH Sells 32,627 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat
Risk Hedge: Is Diebold Nixdorf Incorporated a good ESG investmentRate Cut & Precise Swing Trade Alerts - baoquankhu1.vn
Sell Signal: Will Soleno Therapeutics Inc outperform the market in YEAR2025 Key Highlights & Verified Swing Trading Watchlist - baoquankhu1.vn
Soleno Therapeutics stock hits 52-week low at 39.42 USD By Investing.com - Investing.com South Africa
Soleno Therapeutics Shares Dip Following $200 Million Stock Offering Pricing - MSN
Soleno Therapeutics (NASDAQ:SLNO) Hits New 52-Week LowShould You Sell? - MarketBeat
Soleno Therapeutics stock hits 52-week low at 39.42 USD - Investing.com
SLNO Stock Rallies on FDA Approval of Prader-Willi Syndrome Drug - MSN
Soleno Therapeutics to Participate in Upcoming Conferences - The Manila Times
Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC) and Soleno Therapeutics (SLNO) - The Globe and Mail
Solena Therapeutics (SLNO) Stock Under Pressure But Upside is Huge - Finviz
Soleno Therapeutics (SLNO) Stock Analysis: Unveiling a Potential 164% Upside in the Biotech Arena - DirectorsTalk Interviews
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Liquidity Mapping Around (SLNO) Price Events - Stock Traders Daily
Soleno Therapeutics Updates Executive Compensation and Severance Plans - The Globe and Mail
Is Soleno Therapeutics, Inc. (NASDAQ:SLNO) The Best Under $50 Stock to Buy Now? - Insider Monkey
Emerald Mutual Fund Advisers Trust Reduces Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat
Soleno Therapeutics Inc. (SLNO): Analysts See Major Upside - Finviz
Soleno Therapeutics (SLNO) Valuation Checked After New Q4 2025 Revenue Guidance - Sahm
FY2025 Earnings Estimate for SLNO Issued By HC Wainwright - MarketBeat
Emerald Advisers LLC Trims Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat
SLNO INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Soleno Therapeutics, Inc. - ACCESS Newswire
Q2 EPS Estimate for Soleno Therapeutics Increased by Analyst - MarketBeat
Soleno Therapeutics stock price target raised to $120 from $110 at H.C. Wainwright - Investing.com Nigeria
Soleno Therapeutics stock price target raised to $120 from $110 at H.C. Wainwright By Investing.com - Investing.com South Africa
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):